AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2018
Jun 15, 2018
31949_dirs_2018-06-15_0919d4b6-c98a-47e1-ba4f-3035890d4fbd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-06-13
Reporting Person: Danziger Asaf (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-13 | Ordinary Shares | S | 11720 | $32.00 | Disposed | 171100 | Direct |
| 2018-06-14 | Ordinary Shares | S | 200 | $32.00 | Disposed | 170900 | Direct |
Footnotes
F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3